微信小陈
微信小章| 产品名称： | Streptomyces himastatinicus |
|---|---|
| 商品货号： | TS177750 |
| Deposited As： | Streptomyces hygroscopicus subsp. hygroscopicus (Jensen) Waksman and Henrici |
| Strain Designations： | C39108 Bu3730T, P210-51# |
| Application： | Produces himastatin |
| Isolation： | Soil, India |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | frozen |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Preceptrol®： | no |
| Type Strain： | yes |
| Medium： | ATCC® Medium 196: Yeast malt extract agar |
| Growth Conditions： | Temperature: 26.0°C |
| Name of Depositor： | Bristol-Myers Co. |
| U.S. Patent Number： | |
| References： | Leet JE, et al. Himastatin, a new antitumor antibiotic from Streptomyces hygroscopicus. III. Structural elucidation. J. Antibiot. 49: 299-311, 1996. PubMed: 8626248 Lam KS, et al. Himastatin, a new antitumor antibiotic from Streptomyces hygroscopicus. I. Taxonomy of producing organism, fermentation and biological activity. J. Antibiot. 43: 956-960, 1990. PubMed: 2211362 Leet JE, et al. Himastatin, a new antitumor antibiotic from Streptomyces hygroscopicus. II. Isolation and characterization. J. Antibiot. 43: 961-966, 1990. PubMed: 2211363 Kumar Y, Goodfellow M. Five new members of the Streptomyces violaceusniger 16S rRNA gene clade: Streptomyces castelarensis sp. nov., comb. nov., Streptomyces himastatinicus sp. nov., Streptomyces mordarskii sp. nov., Streptomyces rapamycinicus sp. nov. and Streptomyces ruanii sp. nov. Int. J. Syst. Evol. Microbiol. 58: 1369-1378, 2008. PubMed 18523180 |